OTCM
SYUP
Market cap15kUSD
Dec 09, Last price
0.00USD
Name
ANBC Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shanghai Yutong Pharma, Inc., a company based in Shanghai, China, specializes in the development, manufacturing, and distribution of both traditional Chinese herbal remedies and cutting-edge biological pharmaceuticals within the People's Republic of China. Their diverse product portfolio addresses a wide range of health concerns. Noteworthy offerings include Qilisheng, crafted to strengthen the immune system and promote overall vitality. Oral solutions such as Qi-ju-di-huang are formulated to support kidney and liver function, while Qing-re-jie-du serves to reduce fever and alleviate heat. Sheng-mai-yin is designed to conserve vital energy and replenish bodily fluids, and Xiao-qing-long provides relief from coughs and difficulty breathing. The company also produces various syrups: Shen-bao targets the treatment of impotence and spermatorrhoea; Ban-xia offers cough suppression; and Gan-mao-zhi-ke combats symptoms of the flu, coughs, and nasal congestion. Further herbal preparations encompass Ban-lan-gen for common cold and influenza relief; Gan-mao-qing-re, which helps to mitigate minor body aches, pains, and fever; Huang-dan-yin-chen, utilized in managing jaundice and infectious hepatitis; and Liu-shen-qu, prescribed for instances of vomiting and dysentery. These pharmaceutical goods are supplied to distributors via a wholesale model.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY |
|---|---|---|
| 2017‑12 | 2016‑12 | |
| Income | ||
Revenues | ||
Cost of revenue | ||
Unusual Expense (Income) | ||
NOPBT | ||
NOPBT Margin | ||
Operating Taxes | ||
Tax Rate | ||
NOPAT | ||
Net income | ||
Dividends | ||
Dividend yield | ||
Proceeds from repurchase of equity | ||
BB yield | ||
| Debt | ||
Debt current | ||
Long-term debt | ||
Deferred revenue | ||
Other long-term liabilities | ||
Net debt | ||
| Cash flow | ||
Cash from operating activities | ||
CAPEX | ||
Cash from investing activities | ||
Cash from financing activities | ||
FCF | ||
| Balance | ||
Cash | ||
Long term investments | ||
Excess cash | ||
Stockholders' equity | ||
Invested Capital | ||
ROIC | ||
ROCE | ||
| EV | ||
Common stock shares outstanding | ||
Price | ||
Market cap | ||
EV | ||
EBITDA | ||
EV/EBITDA | ||
Interest | ||
Interest/NOPBT | ||